interestingly, the af-4 transactivation domain is retained in the mll/af-4 fusion protein; thus, it may contribute to the transforming potential of the oncoprotein.
The cloning of LAF-4 has defined a new family of potential regulatory proteins that may function in lymphoid development and oncogenesis.